BSC and AstraZeneca Sign Agreement to Advance AI and Supercomputing Applied to Healthcare
Pharmaceutical major and Spanish research institute partner to deploy supercomputing in therapy discovery

The Barcelona Supercomputing Center and pharmaceutical company AstraZeneca have entered into a strategic collaboration agreement to apply advanced computational tools to biomedical science. The partnership will pursue high-impact initiatives across therapy discovery, data analytics, and healthcare research. The tie-up aims to expedite scientific workflows using regional high-performance computing infrastructure.
Original source
This summary was written by the GPU Data Hub desk from reporting published by HPCwire on 30 Oct 2026, 07:05. Read the full article at the original publisher.
Read Original Source →